Guest guest Posted February 13, 2010 Report Share Posted February 13, 2010 Finasteride has been shown to reduce the incidence of prostate cancer. Yet the use of finasteride remains low, likely because of the risk of adverse effects. This study sought to determine whether prostate-specific antigen (PSA) levels could identify a high-risk subgroup for which the benefits of finasteride treatment outweigh the potential harms....Click on the below link for the full story:<http://www.urotoday.com/index.php?option=com_content & task=view_ua & id=2227261>Non-doctors are welcome to browse UroToday.com but you'll be requested to register, which you can safely do, since this professional medical site never sends spam! Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.